Cargando…
Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [(11)C]-carfentanil PET and fMRI study
BACKGROUND: Reward processing deficits are a core feature of schizophrenia and are thought to underlie negative symptoms. Pre-clinical evidence suggests that opioid neurotransmission is linked to reward processing. However, the contribution of Mu Opioid Receptor (MOR) signalling to the reward proces...
Autores principales: | Shatalina, Ekaterina, Ashok, Abhishekh H., Wall, Matthew B., Nour, Matthew M., Myers, Jim, Reis Marques, Tiago, Rabiner, Eugenii A., Howes, Oliver D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400918/ https://www.ncbi.nlm.nih.gov/pubmed/37517175 http://dx.doi.org/10.1016/j.nicl.2023.103481 |
Ejemplares similares
-
Reduced mu opioid receptor availability in schizophrenia revealed with [(11)C]-carfentanil positron emission tomographic Imaging
por: Ashok, Abhishekh H., et al.
Publicado: (2019) -
O5.5. THE NEUROBIOLOGY OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: MULTI-MODAL PET AND FMRI FINDINGS
por: Howes, Oliver, et al.
Publicado: (2020) -
Acute acetate administration increases endogenous opioid levels in
the human brain: A [(11)C]carfentanil molecular imaging
study
por: Ashok, Abhishekh H, et al.
Publicado: (2021) -
[(11)C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue
por: Sun, Lihua, et al.
Publicado: (2022) -
The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys
por: Scott, Peter J. H., et al.
Publicado: (2020)